Who Just Raised

Abcuro, Inc.

Newton, MA ยท Biotechnology

Abcuro, Inc. is a biotechnology company based in Newton, Massachusetts. In a Form D filed with the SEC on August 13, 2026, it reported raising $39,383,108 from 23 investors as part of an offering of up to $176,522,953. The first sale in the offering took place on August 7, 2026.

22% of the $177M offering sold so far

The determination of people living with inclusion body myositis inspires our work and strengthens our resolve to advance precision therapies with the potential to change what's possible.

Website
abcuro.com
Amount raised
$39,383,108
Offering size
$176,522,953
Investors so far
23
First sale
August 7, 2026
Securities offered
Equity
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Newton, Massachusetts
Incorporated
Delaware
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $39,383,108 $176,522,953 23 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Massachusetts

Company Location Sector Raised Target Filed
Axelyf, Inc. Chestnut Hill, MA Health Care $2.6M $2.7M
Soterya, Inc. Boston, MA Health Care $850K $2M
Bioventrix, Inc. Mansfield, MA Health Care $1.2M $3M
Opus KSD, Inc. Pembroke, MA Health Care $681K $681K
Xact Bio, Inc. Boston, MA Health Care $10M $18M
Way Biosolutions, Inc. Cambridge, MA Health Care $2M $2M